Intra-Cellular Therapies, Inc. - COM (ITCI)

Q4 2023 13F Holders as of 12/31/2023

Type / Class
Equity / COM
Number of holders
328
Total Shares
89.3M
Shares change
+3.33M
Total reported value, excl. options
$6.4B
Value change
+$284M
Put/Call ratio
0.43
Number of buys
164
Number of sells
-137
Price
$71.62
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.